作者: P. J. Vickers , C. Deluca , E. Wong , M. Abramovitz
DOI: 10.1007/978-1-4615-5325-0_21
关键词: Transfection 、 Arachidonic acid 、 Substrate (chemistry) 、 Enzyme 、 5-lipoxygenase-activating protein 、 Biochemistry 、 Chemistry 、 Integral membrane protein 、 Arc (protein) 、 Arachidonate 5-lipoxygenase
摘要: Transfection studies in human osteosarcoma cells have demonstrated that the enzyme 5-lipoxygenase (5-LO) and integral membrane protein activating (FLAP) are both required for cellular synthesis of leukotrienes (LTs) (1). Consequently compounds which directly inhibit 5-LO (2) or specifically interact with FLAP (3,4) arc potent inhibitors LT currently being asseed treatment diseases LTs implicated.